Lok Sabha Question No. 212 (STARRED), answered on 2026-02-13
Subject: Performance of AYUSH Suraksha Portal
Ministry: AYUSH
Asked by: Adv. Chandra Shekhar

## GOVERNMENT OF INDIA MINISTRY OF AYUSH

## LOK SABHA STARRED QUESTION NO. 212 TO BE ANSWERED ON 13 th  FEBRUARY 2026

## Performance of AYUSH Suraksha Portal

## * 212. Adv. Chandra Shekhar:

Will the Minister of AYUSH be pleased to state:

- (a) the  details  of  the  performance  of  AYUSH  Suraksha  Portal  since  its  launch  in  2025, including  number  of  misleading  advertisement  complaints  received,  ADRs  reported, actions  taken  and  integration  with State  Licensing  Authorities/CDSCO as  of January 2026;
- (b) the steps taken by the Government to ensure effective enforcement amid concerns that portal usage remains low and enforcement gaps persist post-Supreme Court directives; and
- (c) the manner in which the portal aligns with World Health Organisation (WHO) guidelines on  ethical  marketing  of  traditional  medicines  and  World  Bank  recommendations  on strengthening regulatory systems for consumer protection in health products?

## ANSWER

## THE MINISTER OF STATE (IC) OF THE MINISTRY OF AYUSH (SHRI PRATAPRAO JADHAV)

(a) to (c) A statement is laid on the Table of the House.

## THE STATEMENT REFERRED TO IN REPLY TO LOK SABHA STARRED QUESTION NO. 212 FOR 13 th  FEBRUARY 2026.

(a) and (b) Ministry of Ayush has launched an IT enabled online portal 'Ayush Suraksha' to track the  reported  Misleading  Advertisements  (MLAs)/Objectionable  Advertisements  (OAs)  and Adverse Drug Reactions (ADRs) on 30th May 2025.The portal features a centralized dashboard for capturing of MLAs/OAs and tracking of suspected ADRs for prompt regulatory action and comprehensive data analysis.

The  portal has  been aligned with the National Pharmacovigilance Program through its three-tier network like Peripheral Pharmacovigilance Centres (PPvC), Intermediary Pharmacovigilance Centres (IPvC) and National Pharmacovigilance Coordination Centre (NPvCC). Further,  the  portal  is  integrated  with  State/UTs  (Ayush)  Licensing  Authorities,  and Central  Government  bodies  like  Ministry  of  Information  and  Broadcasting  (MoI&B),  Central Consumer Protection Authority (CCPA), National Commission for Indian System of Medicine (NCISM), National Commission for Homoeopathy (NCH), Press Council of India (PCI) and Food Safety and Standards Authority of India (FSSAI) for taking appropriate action.

The portal also allows consumers, Ayush healthcare professionals to report MLAs /OAs, ADRs and regulatory authorities to monitor them. All complaints on the portal can be reviewed by National  Pharmacovigilance  Coordination  Centre  (NPvCC)  and  Ministry  of  Ayush,  thus promoting transparency and accountability in the regulatory framework.

All MLAs/OAs and suspected ADRs submitted on the portal since its launch till January 2026 were already forwarded to concerned authorities for further necessary action. The details are attached at Annexure-I.

As per the information received from State/UT Governments, the details of action taken on Misleading Advertisements (MLAs)/Objectionable Advertisements (OAs) submitted on the portal since its launch till January 2026 are attached at Annexure-II.

Further, in pursuance of clause (b) of sub-section (3) of section 79 of the Information Technology Act, 2000 (21 of 2000) read with clause (d) of sub-rule (1) of rule 3 of the Information Technology  (Intermediary  Guidelines  and  Digital  Media  Ethics  Code)  Rules,  2021,  Central Government  vide  Gazette  notification  no  S.O.  5323(E)  dated  19/11/2025  designated,  the Coordinator, National Pharmacovigilance Coordination Centre, All India Institute of Ayurveda,

New Delhi, as the nodal officer for the purpose of issuing notice to intermediaries in relation to any information,  data  or  communication  link  residing  in  or  connected  to  a  computer  resource controlled by the intermediary being used to commit the unlawful act, in respect to the Drugs and Magic  Remedies  (Objectionable  Advertisements)  Act,  1954  (21  of 1954), the National Commission for Indian System of Medicine Act, 2020 (14 of 2020) and the National Commission for Homeopathy Act, 2020 (15 of 2020).

To ensure effective enforcement, regular citizen-centric awareness and outreach programs have been conducted since the launch of the portal. Further, State/UTs Licensing Authorities has been sensitized on Ayush Suraksha Portal and for taking actions to curb misleading advertisements in the training program conducted on 09.01.2026 at Gandhinagar, Gujarat.

(c)  The  objectives  of  Pharmacovigilance  system  in  Ayush  is  aligned  with  the  World  Health Organization (WHO) Global Traditional Medicine Strategy (2025-2034).  The portal also aligns with  the  WHO  Guidelines  on 'Safety  Monitoring  of  Herbal  Medicines in  Pharmacovigilance Systems  (2004) ' ,  which  emphasize  that  the  safety  of  herbal  medicines  should  be  monitored through national pharmacovigilance systems integrated within existing regulatory frameworks to improve risk detection  and protect public health by establishing  a pharmacovigilance network involving national centres, health facilities, pharmacies, consumers, and manufacturers so that all stakeholders participate in reporting adverse events.

*****

## Annexure-I

The  details  of  Misleading  Advertisements  (MLAs)/Objectionable  Advertisements  (OAs)  and suspected Adverse Drug Reactions (ADRs) submitted on the portal since its launch till January 2026 are :

| Misleading Advertisements (MLAs)/Objectionable Advertisements (OAs) and suspected Adverse Drug Reactions (ADRs) submitted to portal   | Misleading Advertisements (MLAs)/Objectionable Advertisements (OAs) and suspected Adverse Drug Reactions (ADRs) submitted to portal   | Misleading Advertisements (MLAs)/Objectionable Advertisements (OAs) and suspected Adverse Drug Reactions (ADRs) submitted to portal   |
|---------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------|
| Submitted by                                                                                                                          | MLAs/OAs                                                                                                                              | Suspected ADR's                                                                                                                       |
| Public                                                                                                                                | 53                                                                                                                                    | 0                                                                                                                                     |
| NPvCC, All India Institute of Ayurveda, New Delhi                                                                                     | 46                                                                                                                                    | 0                                                                                                                                     |
| IPvC, Institute of Teaching and Research in Ayurveda, Jamnagar                                                                        | 810                                                                                                                                   | 57                                                                                                                                    |
| IPvC, National Institute of Ayurveda, Jaipur                                                                                          | 4763                                                                                                                                  | 63                                                                                                                                    |
| IPvC, National Institute of Homoeopathy, Kolkata                                                                                      | 288                                                                                                                                   | 0                                                                                                                                     |
| IPvC, National Institute of Unani Medicine, Bengaluru                                                                                 | 2030                                                                                                                                  | 49                                                                                                                                    |
| IPvC, National Institute of Siddha, Chennai                                                                                           | 1080                                                                                                                                  | 24                                                                                                                                    |
| Total                                                                                                                                 | 9070                                                                                                                                  | 193                                                                                                                                   |

## Annexure-II

As  per  the  information  received  from  State/UT  Governments,  the  details  of  action  taken  on Misleading Advertisements (MLAs)/Objectionable Advertisements (OAs) submitted on the portal since its launch till January 2026 are as follows:

|   S. No. | States/UTs Governments   | No of complaints received on portal   | Action Taken thereon   |
|----------|--------------------------|---------------------------------------|------------------------|
|        1 | Odisha                   | 232                                   | 213                    |
|        2 | Gujarat                  | 136                                   | 136                    |
|        3 | Uttarakhand              | 225                                   | 225                    |
|        4 | Madhya Pradesh           | 910                                   | 204                    |
|        5 | Tripura                  | 42                                    | 15                     |
|        6 | Kerala                   | 103                                   | 52                     |
|        7 | Maharashtra              | 1024                                  | 1024                   |
|        8 | Tamil Nadu               | 714                                   | 551                    |
|        9 | Haryana                  | Nil                                   | -                      |
|       10 | Arunachal Pradesh        | Nil                                   | -                      |
|       11 | Goa                      | Nil                                   | -                      |
|       12 | Puducherry               | Nil                                   | -                      |
|       13 | Himachal Pradesh         | Nil                                   | -                      |
|       14 | Uttar Pradesh            | Nil                                   | -                      |
|       15 | Mizoram                  | Nil                                   | -                      |